391 – 400 of 540
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: Implications for breast and ovarian cancer risk.
(
- Contribution to journal › Article
-
Mark
Fat from different foods show diverging relations with breast cancer risk in postmenopausal women.
(
- Contribution to journal › Article
-
Mark
The impact of reproductive factors on breast cancer risk - The feasibility of using Swedish population-based registers to account for the effect of confounding in cohort studies
(
- Contribution to journal › Article
-
Mark
Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Predicting the Outcome of Optic Neuritis Evaluation of risk factors after 30 years of follow-up.
(
- Contribution to journal › Article
-
Mark
Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
(
- Contribution to journal › Article
-
Mark
Use of Swedish moist snuff, smoking and alcohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma: A population-based case-control study in southern Sweden
(
- Contribution to journal › Article
-
Mark
Histopathological and cell biological characteristics of ductal carcinoma in situ (DCIS) of the breast-a comparison between the primary DCIS and subsequent ipsilateral and contralateral tumours.
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
(
- Contribution to journal › Article